Lyniate, the newly named US owner of the Rhapsody integration engine first developed by Auckland firm Orion Health, has entered into a merger agreement with NextGate, which markets identity resolution and enterprise master person index systems widely used in Australia and New Zealand.
Orion Health was forced to sell its crown jewel in Rhapsody in 2018 when it delisted from the Australian stock exchange. Rhapsody was sold to British private investment firm Hg that year, and in 2019 was merged with American healthcare integration company Corepoint Health, later renamed as Lyniate.
